Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer's drug candidates.
Leuci R, Simic S, Carrieri A, Chaves S, La Spada G, Brunetti L, Tortorella P, Loiodice F, Laghezza A, Catto M, Santos MA, Tufarelli V, Wackerlig J, Piemontese L.
Leuci R, et al. Among authors: la spada g.
Bioorg Chem. 2024 Dec;153:107895. doi: 10.1016/j.bioorg.2024.107895. Epub 2024 Oct 18.
Bioorg Chem. 2024.
PMID: 39454499
Free article.